ArticleClinical and experimental hepatology2021

Change in γ-glutamyl transpeptidase activity as a useful tool in identifying a group of patients with elevated risk of hepatocellular carcinoma development after DAA treatment of chronic hepatitis C.

Dorota Orzechowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.